Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

medRxiv(2021)10.1101/2021.01.22.21250208Source: DataRank Database

Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (17)IDs (PubMed, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Sarah Pett ORCID,Leanne McCabe ORCID,Christopher R. Jones ORCID,Richard Gilson ORCID,Sumita Verma ORCID

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W3159967499

Wellcome Trust

Grant: 206296

SouthEast Asian Research Collaboration in Hepatitis (SEARCH)

UK Research and Innovation

Grant: MC_UU_12023/22

Other infectious diseases of global public health significance

UK Research and Innovation

Grant: MR/K01532X/1

Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection

Wellcome Trust

Grant: 090532

Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics.

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/01/26/2021.01.22.21250208.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.01.22.21250208

repositoryhttps://doi.org/10.1101/2021.01.22.21250208

http://sro.sussex.ac.uk/id/eprint/99483/1/STOP%20HCV%201.pdf

Fields of Study

Hepatitis C virus researchLiver Disease Diagnosis and TreatmentHepatitis B Virus Studies0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

RibavirinMedicineSofosbuvirLedipasvirInternal medicineHepatitis CChronic hepatitisGastroenterologyVirologyVirusResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being